OVER-THE-COUNTER DRUGS - THE ISSUES

被引：14

作者：

CRANZ, H

机构：

[1] European Proprietary Manufacturers’ Association, Paris, F93120, 70 rue du Gouverneur Général Eboué, Issy les Moulineux

来源：

DRUG SAFETY | 1990年 / 5卷

关键词：

D O I：

10.2165/00002018-199000051-00019

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

Self-medication is recognised today as an important part of health-care systems. Empirical studies worldwide show that most consumers use self-medication preparations in a safe and proper way. Because of this, a liberal regulatory environment, concerning, in particular, the change from prescription to nonprescription status, seems appropriate. This must be combined with a comprehensive information package in consumer-oriented language. The characteristics for self-medication medicines which were developed by WHO might provide guidance for the national policies in that area. © 1990, ADIS Press Limited. All rights reserved.

引用

页码：120 / 125

页数：6

共 6 条

[1]

Cranz H., The future of self-medication, In Drugs made in Germany, 30, (1987)

[2]

Cranz H., Selbstmedikation — Analysen und Perspektiven, pp. 109-119, (1987)

[3]

Everyday health care, (1987)

[4]

Gutscher H., Hornung R., May U., Schar M., Selbstmedikation. Ergebnisse einer Repräsentativerhebung im Rahmen des Nationalen Forschungsprogramms 8, (1984)

[5]

A consumer survey on self-medication, (1984)

[6]

Kline C.H., The economic benefits of self-medication, Self-care, self-medication in America’s future, pp. 15-18, (1988)

← 1 →